Flumazenil: potential implications for hepatic encephalopathy.
Jones
E A
EA
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Basile
A S
AS
Mullen
K D
KD
Gammal
S H
SH
D000818:Animals; D005442:Flumazenil / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans
D005442:Flumazenil